"The launch of EVO Viva significantly expands the market opportunity for our EVO family of lenses to now include lenses for patients suffering from presbyopia in the over 30 countries that currently ...
Innovative EVO Viva Implantable Collamer® Lens Corrects Near, Intermediate and Distance Vision The EVO Viva™ lens is a new treatment option for potential future consideration by the 1.7 billion people ...
Medical Device Network on MSN
Alcon spends up to $200M to co-develop customisable cataract lenses with RxSight
The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...
“We are excited to introduce Vivity because it addresses some common concerns of surgeons and cataract patients alike when considering presbyopia-correcting IOLs (PC-IOLs),” said Michael Onuscheck, ...
Alcon and RxSight, Inc have announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting ...
Please provide your email address to receive an email when new articles are posted on . For almost 20 years now, we have been using presbyopia-correcting lens implants. But an important caveat that ...
As technology evolves, there is potential to quantify and automate presbyopia-correcting IOL selection through measures that ...
Patients now have several exciting—although not yet perfect—multifocal intraocular lenses (IOLs) for presbyopia correction from which to choose. Currently in the United States, the recently approved ...
When it comes to refractive surgery, not all patients are created equal. A 28-year-old patient with myopia desiring to be ...
GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available in select European ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results